These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4579955)

  • 1. Controlled trial of clofibrate in cerebral vascular disease.
    Acheson J; Hutchinson EC
    Atherosclerosis; 1972; 15(2):177-83. PubMed ID: 4579955
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of essential hyperlipidaemia.
    Fredrickson DS; Levy RI
    Lancet; 1970 Jan; 1(7639):191-2. PubMed ID: 4189261
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of fenofibrate and clofibrate hypolipidemic effects.
    Daubresse JC
    Acta Clin Belg; 1980; 35(4):227-32. PubMed ID: 7015771
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of methyl clofenapate (a derivative of clofibrate) in patients with essential hyperlipidaemias--with special reference to type II (primary) hyperlipidaemia.
    Craig GM; Walton KW
    Atherosclerosis; 1972; 15(2):189-98. PubMed ID: 4579956
    [No Abstract]   [Full Text] [Related]  

  • 5. Clofibrate and niacin in coronary heart disease.
    JAMA; 1975 Jan; 231(4):360-81. PubMed ID: 1088963
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofibrate for the treatment of occlusive cerebrovascular disease.
    Hirsch SB; Wechsler AF; Tourtellotte WW
    N Engl J Med; 1972 Sep; 287(13):671. PubMed ID: 4561834
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined effects of clofibrate and diosgenin on cholesterol metabolism in rats.
    Cayen MN; Dvornik D
    Atherosclerosis; 1978 Mar; 29(3):317-27. PubMed ID: 208586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clofibrate and its derivative methyl clofenapate.
    Craig GM
    Atherosclerosis; 1972; 15(2):265-71. PubMed ID: 4666129
    [No Abstract]   [Full Text] [Related]  

  • 10. The treatment of cerebrovascular disease with clofibrate. Final report of the Veterans Administration Cooperative Study of Atherosclerosis, Neurology Section.
    Stroke; 1973; 4(4):684-93. PubMed ID: 4723698
    [No Abstract]   [Full Text] [Related]  

  • 11. [Etofibrate and clofibrate in double blind study].
    Rahlfs VW; Zimmermann H; Safer A
    Dtsch Med Wochenschr; 1976 Jul; 101(31):1168-9. PubMed ID: 789039
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and metabolic effects of pentaerythritol tetranicotinate in combination with cholesolvin or clofibrate.
    Olsson AG; Orö L; Rössner S
    Atherosclerosis; 1974; 19(3):407-15. PubMed ID: 4364073
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
    Smith FR; Noble RP; Goodman DS
    Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate).
    Bergqvist N
    Acta Med Scand; 1970 Mar; 187(3):213-8. PubMed ID: 5444978
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
    Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
    Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: Etofibrate and clofibrate in double blind study].
    Knipping W; Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1976 Apr; 101(16):627-9. PubMed ID: 770108
    [No Abstract]   [Full Text] [Related]  

  • 18. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
    Zelis R; Amsterdam EA; Spann JF; Mason DT
    JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
    [No Abstract]   [Full Text] [Related]  

  • 19. [Overviews of fibrate].
    Tada N
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of essential hyperlipemia with clofibrate].
    Reuter W; Seifert A
    Z Gesamte Inn Med; 1969 Jun; 24(12):184-7. PubMed ID: 5404292
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.